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Abstract
Recent reports have suggested the involvement of gut microbiota in the progression of colorectal cancer (CRC). We utilized
pyrosequencing based analysis of 16S rRNA genes to determine the overall structure of microbiota in patients with
colorectal cancer and healthy controls; we investigated microbiota of the intestinal lumen, the cancerous tissue and
matched noncancerous normal tissue. Moreover, we investigated the mucosa-adherent microbial composition using rectal
swab samples because the structure of the tissue-adherent bacterial community is potentially altered following bowel
cleansing. Our findings indicated that the microbial structure of the intestinal lumen and cancerous tissue differed
significantly. Phylotypes that enhance energy harvest from diets or perform metabolic exchange with the host were more
abundant in the lumen. There were more abundant Firmicutes and less abundant Bacteroidetes and Proteobacteria in
lumen. The overall microbial structures of cancerous tissue and noncancerous tissue were similar; howerer the tumor
microbiota exhibited lower diversity. The structures of the intestinal lumen microbiota and mucosa-adherent microbiota
were different in CRC patients compared to matched microbiota in healthy individuals. Lactobacillales was enriched in
cancerous tissue, whereas Faecalibacterium was reduced. In the mucosa-adherent microbiota, Bifidobacterium,
Faecalibacterium, and Blautia were reduced in CRC patients, whereas Fusobacterium, Porphyromonas, Peptostreptococcus,
and Mogibacterium were enriched. In the lumen, predominant phylotypes related to metabolic disorders or metabolic
exchange with the host, Erysipelotrichaceae, Prevotellaceae, and Coriobacteriaceae were increased in cancer patients.
Coupled with previous reports, these results suggest that the intestinal microbiota is associated with CRC risk and that
intestinal lumen microflora potentially influence CRC risk via cometabolism or metabolic exchange with the host. However,
mucosa-associated microbiota potentially affects CRC risk primarily through direct interaction with the host.
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Introduction
Colorectal cancer (CRC) is one of the most common malignant
tumor type in the world. One of the important factors associated
with CRC is the intestinal microbiota [1]. The human gastroin-
testinal tract harbors approximately 1000 species of bacteria
totaling 10
14 cells, which is more than 10-fold the number of
eukaryotic human cells [2]. In addition to influencing host
nutrition via metabolism, the intestinal microbiota affects the
human body by controlling epithelial proliferation and differen-
tiation, influencing the development of the immune system and
protecting against pathogens [3].
Accumulating evidence suggests that the gut microbiota is
closely correlated with the progression of colorectal cancer [1,4].
Wei et al. found an increase of Ruminococcus obeum and Allobaculum-
like bacteria in the feces of rats developing precancerous mucosal
lesions [5]. An increase of Prevotella was reported in CRC patients
[6]. Wang et al. found a reduction in butyrate-producing bacteria
in the feces of CRC patients [7], indicating the benefit of bacterial
metabolites.
However, the mucosa-associated microbiome in intestinal tissue
differs from the lumen [8], and these microbes also potentially play
important roles. Marchesi and coworkers analyzed the bacterial
16S rDNA sequences of six CRC patients and determined that
probiotic bacteria such as Coriobacteria were enriched in tumor
tissue by analyzing the bacterial 16S rDNA sequences of six CRC
patients [9], suggesting that probiotics potentially play a special
role in CRC progression. Fusobacterium nucleatum found in colon
cancer tissue was reported to be closely associated with CRC [10].
However, the exact composition of intestinal microbiota and its
function in CRC progression are remain unknown because the
overall structure of microbiota in CRC patients has not been
completely elucidated.
Bacteria or components of bacteria function by direct interac-
tion with the host or indirect co-metabolism or metabolic
exchange with the host. Van der Waaij et al. found that commensal
bacteria live in the intestinal lumen suspension and have no direct
contact with epithelial cells [11]. We hypothesized that the
mucosa-associated microbiota primarily function by directly
interacting with the host and that intestinal lumen (i.e., stool)
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exchange. In this study we performed pyrosequencing of 16S
rRNA genes in order to analyze the overall structure of microbiota
in patients with CRC and in healthy controls. We studied the
microbiota of the intestinal lumen, cancerous tissue, and matched
noncancerous normal tissue. In addition, we examined the
mucosa-adherent microbial composition by using rectal swab
samples because the structure of the tissue-adherent bacterial
community is potentially altered by following bowel cleansing
[12]. Moreover, we attempted to identify key bacterial phylotypes
or potential biomarkers that potentially play important roles in
CRC development.
Materials and Methods
Patients and Control Groups
A total of 46 patients with CRC 37–88 years of age were
selected from the First Affiliated Hospital, College of Medicine,
Zhejiang University, China. We gathered the following samples
from these patients: [21 stool (stp) samples, 32 gut swab (swp)
samples and 27 of each of cancerous tissue (cat), matched
paracancerous tissue 2–5 cm from the cancerous tissue (pa2t),
and matched paracancerous tissue 10–20 cm from the cancerous
tissue (pa10t)]. The stool, rectal swab, and tissue samples were not
collected from all CRC patients for the following reasons: watery
stool, stool too thin to collect; samples stored too long at room
temperature; or the patient felt uncomfortable during the
collection of rectal swab samples. Additionally, 56 healthy
volunteers who met the requirements of having matched gender
and similar age with the samples of CRC patients, and who
exhibited no colonic adenomas were selected as controls; 22 stool
samples (stc) and 34 swabs (swc) were collected from these
volunteers (Table 1). We defined microbiota of tissue, stool, and
swab as tissue microbiota, lumen microbiota, and mucosa-
adherent microbiota, respectively. We defined both tissue micro-
biota and mucosa-adherent microbiota as mucosa-associated
microbiota. No study subjects had diabetes, infectious diseases,
or particular diets. And the BMI of all subjects was between 20
and 24. This study was approved by the Ethics Committee of the
First Affiliated Hospital, College of Medicine, Zhejiang University,
China; documented informed consent was obtained from all study
participants.
Sample Collection and DNA Extraction
None of the subjects were taking medications at the time of
sample collection, nor had they used antibiotics within at least one
month of sample collection. Swab and fecal samples were collected
from each subject prior to bowel cleansing. During surgery,
intestinal samples were collected from cancerous tissue and
paracancerous tissue (i.e., 2–5 cm and 10–20 cm from the
cancerous tissue, respectively). All samples were frozen and stored
at 280uC until further use.
Genomic DNA was extracted from tissue and swab samples by
using the QIAamp DNA Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions with minor modifi-
cations. Bacterial cells in swabs were dislodged by vigorous
agitation in 1 ml PBS. The cells were pelleted by centrifugation at
17,000 g for 10 min. The pellets were resuspended in 80 ml
enzyme solution (22.5 mg lysozyme powder [catalog no.L6876,
Sigma] and 40 units mutanolysine [catalog no. M9901, Sigma]
dissolved in 80 ml TE per sample) [13], and 100 mg of zirconium
beads (0.1 mm) were added. The mixtures were agitated in a mini-
bead beater (FastPrep, Thermo Electron Corporation, USA) three
times for 40 s each time, and then incubated at 37uC for 40 min
[14]. Subsequent steps were performed according to manufactur-
er’s recommendations. Intestinal tissues were extensively rinsed
with sterile water, homogenized in 80 ml enzyme solution using an
electric homogenizer (PRO Scientific, Oxford, Connecticut, USA),
incubated at 37uC for 40 min, and then completely lysed for 1–3
hours at 56uC in ATL buffer and proteinase K. The 70uC
incubation step was extended from 10 minutes to 30 minutes [8].
Stool bacterial genomic DNA was extracted using QIAamp DNA
Stool Mini Kit with the same modifications as listed above.
Pyrosequencing
PCR amplification of the V1-V3 region of bacterial 16 S rDNA
was performed using universal primers (27F 59-AGAGTTT-
GATCCTGGCTCAG-39, 533R 59-TTACCGCGGCTGCTGG-
CAC-39) incorporating the FLX Titanium adapters and a sample
barcode sequence. The cycling parameters were as follows: 5 min
initial denaturation at 95uC; 25 cycles of denaturation at 95uC
(30 s), annealing at 55uC (30 s), elongation at 72uC (30 s); and
final extension at 72uC for 5 min. Three separate PCR reactions
of each sample were pooled for pyrosequencing. The PCR
products were separated by 1% agarose gel electrophoresis and
purified by using the QIAquick Gel extraction kit (Qiagen). Equal
concentrations of amplicons were pooled from each sample.
Emulsion PCR and sequencing were performed according to the
manufacturer’s recommendations [15].
All pyrosequencing reads were filtered according to barcode
and primer sequences. The resulting sequences were further
screened and filtered for quality and length. Sequences that were
less than 150 nt, contained ambiguous characters, contained over
two mismatches to the primers, or contained mononucleotide
repeats of over six nt were removed [16]. A total of 808,008 high-
quality sequences were produced, accounting for 80.8% of valid
sequences according to barcode- and primer-sequence filtering.
Bioinformatic Analysis
The high-quality sequences were assigned to samples according
to barcodes. Sequences were aligned in accordance with SILVA
alignment [17,18] and clustered into operational taxonomic units
(OTUs). OTUs that reached 97% similarity level were used for
diversity (Shannon), richness (Chao), Good’s coverage, and
Rarefaction curve analysis by using Mothur (version 1.5.0)
http://schloss.micro.umass.edu/[19]. Taxonomical assignments
of OTUs exhibiting 97% similarity were performed by using
Mothur in accordance with SILVA 106 at 80% confidence level.
The heatmap was constructed by using the heatmap 2 function
of the R gplots package and genus information of seven groups
[20]. Unweighted UniFrac distance metrics analysis was per-
formed using OTUs for each sample [21,22], and principal
Table 1. Summary information of samples.
Healthy
volunteers(56) CRC patients(46)
Sample Swab Stool Swab Stool Tissue
No. 34 22 32 21 2763
Male/female 20/14 11/11 21/11 11/10 14/13
Age (mean,
range)
56(42–77) 64(37–84) 65(37–86) 64(37–78) 61(37–81)
32 swabs samples, 21 stool samples and 27 sets of tissue samples were
collected from 46 CRC patients.
doi:10.1371/journal.pone.0039743.t001
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of distance. To select OTUs that exhibited significance in the
structural segregation between groups, a parametric Partial least
squares Discriminant Analysis (PLS-DA) model was generated by
using Simca-P+12.0 (http://www.umetrics.com/). PLS-DA is
utilized in metabolomics, metagenomics and microarray analysis,
and OTUs with variable importance in projection (VIP).1 were
considered to be important contributors to the model [5,23,24,25].
Statistical Analysis
The Mann-Whitney test, t-test, and one-way ANOVA test were
performed using SPSS version 19.0 for Windows.
Data access
The 16 S sequence data generated in this study were submitted
to the GenBank Sequence Read Archive accession number
SRP009633.
Results
Characteristics of Pyrosequencing Results
A total of 808,008 high-quality sequences were produced in this
study, with an average of 4253 sequences per sample. Summary
information is shown in Table 2, and detailed characteristics of
each sample are found in Table S1.
The estimators of community richness (Chao) and diversity
(Shannon) are shown in Table 2. There were statistically
significant differences of Shannon indexes between groups cat
and pa10t (3.7760.67 vs. 4.1360.40, P=0.012), demonstrating
the significantly higher diversity found in noncancerous normal
tissues (i.e., those 10–20 cm from cancerous tissues) compared to
cancerous tissues. Detailed characteristics of each sample are listed
in Table S1. The rarefaction analysis of seven groups shown in
Figure S1 indicates that more phylotypes would most likely be
detected after exploring larger number of sequences. The Good’s
coverage of each group was over 97%, indicating that the 16 S
rDNA sequences identified in these groups represent the majority
of bacteria present in the samples of this study.
Microbial Structures of Intestinal lumen and Cancerous
Tissue Differed Significantly
We studied the stool, rectal swab, and tissue microbiota of
patients with CRC and the stool and rectal swab bacterial
communities of healthy individuals. The overall microbiota
structure for each group at the phylum level is shown in
Figure 1. The dominant phyla of all groups were Firmicutes,
Bacteroidetes, and Proteobacteria. There were 17 phyla and 13
phyla in tissue and swab samples, respectively, and only 9 phyla in
stool samples. The phylum-specific relative abundance of micro-
biota sequences revealed that swab microbiota exhibited a closer
similarity to tissue. The heatmap according to bacterial genus level
also demonstrated the same phenomenon (Figure S2).
To compare the overall microbiota structure in patients with
CRC, the unweighted Unifrac distance matrix was calculated
based on the OTUs of each sample [26]. The results of PCA based
on distance exhibited a significant difference in bacterial structure
in intestinal lumen (i.e., stool). Furthermore, cancerous tissue, and
mucosa-adherent microbiota (i.e., swab) overlapped with some
lumen and tissue microbiota, as demonstrated by the first two
principal component scores, that accounted for 30.57% and
9.12% of total variations (Figure 2A).
There were significant variations in the composition of intestinal
lumen and cancerous tissue at different bacterial levels. A
cladogram representation of the structure of tissue and lumen
microbiota and their predominant bacteria was performed by
LEfSe is shown in Figure 3 [27]; the greatest differences in taxa
between the two communities are displayed. Pyrosequencing data
demonstrated that a greater number of phyla were present in tissue
compared to lumen. The three dominant phyla–Firmicutes
(50.82% vs. 77.59%, P,0.001), Bacteroidetes (26.37% vs.
13.68%, P=0.002), and Proteobacteria (14.51% vs. 5.57%,
P=0.004)–all exhibited statistically significant differences between
cancerous tissue and intestinal lumen. Fusobacteria (4.97% vs.
0.47%, P,0.001) and Synergistetes (0.14% vs. 0%, P=0.002) also
differed between groups. There were 26 statistically significant
differences between cancerous tissue and intestinal lumen at the
family level. The relative abundance of Bacteroidaceae (16.9% vs.
8.3%, P,0.001), Streptococcaceae (10.2% vs. 2.8%, P=0.0029),
Fusobacteriaceae (4.57% vs. 0.47%, P,0.001), Peptostreptococ-
caceae (4.07% vs. 0.89%, P,0.001), Veillonellaceae (2.87% vs.
0.68%, P=0.004), and Pasteurellaceae (2.25% vs. 0.007%,
P,0.001) were significantly higher in cancerous tissue compared
to the intestinal lumen. There was a significantly lower level of
Lachnospiraceae (17.1% vs. 46.7%, P,0.001), Ruminococcaceae
(4.24% vs. 13.3%, P,0.001), and Lactobacillaceae (0.02% vs.
2.88%, P,0.001) in cancerous tissue compared to the intestinal
lumen (Table S2).
The microbial composition was also significantly different at the
genus level, with 43 significantly different genera between
cancerous tissue and intestinal lumen. Bacteroides, Streptococcus,
Prevotella, Fusobacterium, Peptostreptococcus, Haemophilus, Gemella, Veillo-
nella, Granulicatella, Morganella, and Porphyromonas, which constitute
over 1% of the total bacteria in cancerous tissue, exhibited a
relatively higher abundance in cancerous tissue. Pseudobutyrivibrio,
Blautia, Lactobacillus, Roseburia, Dorea and Coprococcus, constituting
which constitute over 1% of the total bacteria in stool, were
relatively more abundant in intestinal lumen compared to in
cancerous tissue. Additional information regarding the differences
between lumen microbiota and cancerous tissue microbiota can be
found in Table S2.
Table 2. Pyrosequencing data summary.
cat(n=27) pa2t(n=27) pa10t(n=27) stc(n=22) stp(n=21) swc(n=34) swp(n=32)
Sequences 38786796 47346904 456461391 41976468 39196516 43496451 40556566
OTUs 3606117 4266108 438684 397668 407660 422666 411668
Chao 8386312 10176218 9446267 9626167 9436130 9636184 9316202
Shannon 3.7760.67* 4.0460.45 4.1360.40* 3.7060.54 3.8960.49 3.9660.44 3.9860.59
*Shannon index between group cat and pa10t was statistically significant different (P=0.012) (t-test). The number of OTUs, richness estimator Chao, and diversity
estimator Shannon were calculated at 3% distance.
doi:10.1371/journal.pone.0039743.t002
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PLoS ONE | www.plosone.org 3 June 2012 | Volume 7 | Issue 6 | e39743Figure 1. Relative abundance of bacterial phyla in microbiota of seven groups of samples. ‘‘Others’’ represents the unclassified bacteria,
Chloroflexi, Deferribacteres, Chlorobi, Deinococcus-Thermus, Acidobacteria, Planctomycetes, Lentisphaerae, Spirochaetes, Synergistetes, Tenericutes,
Verrucomicrobia and Cyanobacteria. The first eight phyla were not apparent in stool samples, and the first four phyla were not apparent in swab
samples.
doi:10.1371/journal.pone.0039743.g001
Figure 2. PCA plots based on unweighted Unifrac metrics. Each symbol represents a sample. (A) group cat, stp and swp; (B) group cat, pa2t
and pa10t; (C) group swp and swc; (D) group stp and stc.
doi:10.1371/journal.pone.0039743.g002
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Noncancerous Normal Tissue
Although lower diversity (Shannon) was observed in microbiota
of cancerous tissues (Table 2), the microbial communities of tumor
and matched noncancerous normal tissues were similar (Figure 1,
Figure S2). According to unweighted Unifrac PCA analysis, the
microbial communities of cancerous tissue and noncancerous
tissue are similar according to PC1 and PC2 (51.37% and 4.35%
explained variance, respectively) (Figure 2B), indicating that there
are not marked differences in the microbial composition of tumor
and noncancerous tissue.
A taxonomy-based comparison was performed to determine
the differences between the microbiota of tumor and noncan-
cerous tissue. There were 12, 17, and 14 phyla and 169, 198,
and 198 genera in the microbiotas of cat, pa2t, and pa10t,
respectively. This was confirmed by Shannon (diversity) analysis.
No statistically significant differences were observed between the
microbial communities of cancerous and noncancerous tissue at
the phylum level. Alphaproteobacteria, which constitute less
than 1% of total bacteria in both pa2t and pa10t, were most
prevalent in cat. Fewer Ochrobactrum genus members were
present in pa2tcompared to cat. The Bacilli class was highly
enriched in cat compared to pa10t. However, genus Bacillus,t o
which Bacilli belong, was less prevalent in cat. The Rumino-
coccaceae family was significantly lower in cat compared to
pa10t. Genus Faecalibacterium, affiliated with Ruminococcaceae,
was also highly enriched in pa10t compared to cat. Genera
Paraprevotella, Parabacteroides, Phascolarctobacterium, Acidocella, and
Methylobacterium exhibited low abundance; however, they were all
statistically enriched in pa10t compared to cat. Moreover, the
relative abundance of bacteria in the samples increased or
decreased gradually in correlation with the distance from the
cancerous tissue (Table 3).
The metagenome analysis approach LefSe was applied to
identify the key phylotypes responsible for the difference between
cat and pa10t. Bacilli (main component Lactobacillales), which
was enriched in cat, and Phascolarctobacterium, Ruminococcaceae
(main component Faecalibacterium), which were enriched in pa10t
were the dominant phylotypes that contribute to the difference
between the microbiota of cancerous tissue and noncancerous
tissue.
Mucosa-adherent Microbiota in CRC Patients and Healthy
Individuals
Because the microbial composition may be changed by bowel
cleansing prior to surgery, mucosa-adherent bacteria were studied
in samples collected on rectal swabs. As expected, the microbial
structure was somewhat different compared to tissue (Figure 1,
Figure 2A) and was similar to intestinal lumen (some samples
overlapped on PCA plots) because of the unavoidable feces on the
swab samples.
Unweighted Unifrac PCA based on the relative abundance of
OTUs for each sample demonstrated a separation between CRC
patients and healthy individuals using PC1 and PC2 (10.64% and
6.58% of explained variance, respectively) (Figure 2C). The
families Porphyromonadaceae (3.86% vs. 1.41%, P=0.045),
Fusobacteriaceae (3.72% vs. 0.18%, P=0.045), and Peptostrepto-
coccaceae (2.13% vs. 0.66%, P=0.03) were enriched in CRC
patients, yet Bifidobacteriaceae (0.03% vs. 0.32%, P,0.001) and
Alcaligenaceae (0.39% vs. 0.63%, P=0.03) were reduced in CRC
patients. Genera Fusobacterium (Fusobacteriaceae), Porphyromonas
(Porphyromonadaceae), Peptostreptococcus (Peptostreptococcaceae),
Gemella, Mogibacterium, and Klebsiella were enriched in CRC
patients. Filifactor, Catonella and Selenomonas were absent from
healthy individuals. Faecalibacterium, Blautia, Lachnospira, Bifidobacter-
ium (Bifidobacteriaceae) and Anaerostipes were reduced in CRC
patients, and Catenibacterium and Gardnerella (Bifidobacteriaceae)
were absent from CRC patient samples (Figure 4).
Porphyromonas (affiliated with Porphyromonadaceae), Fusobacteri-
um, Peptostreptococcus, and Mogibacterium were enriched in CRC
patients, whereas Faecalibacterium, Blautia, and Bifidobacterium were
depleted in these patients. According to LefSe analysis, these are
Figure 3. Different structures of intestinal lumen and cancerous tissue microbiota. (A) Taxonomic representation of statistically and
biologically consistent differences between cancerous tissue and intestinal lumen. Differences are represented by the color of the most abundant
class (Red indicating cancerous tissue, yellow non-significant and green intestinal lumen). The diameter of each circle’s diameter is proportional to the
taxon’s abundance. (B) Histogram of the LDA scores for differentially abundant genera. Cladogram was calculated by LEfSe, a metagenome analysis
approach which performs the linear discriminant analysis following the Wilcoxon Mann-Whitney test to assess effect size of each differentially
abundant taxon or OTU; the cladogram is displayed according to effect size.
doi:10.1371/journal.pone.0039743.g003
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mucosa-adherent microbiota in CRC patients and healthy
individuals.
Microbial Composition of Intestinal Lumen in CRC
Patients and Healthy Individuals
The intestinal lumen microbiota of CRC patients could be
differentiated from healthy individuals according to unweighted
Unifrac PCAanalysis (Figure2D). The families Erysipelotrichaceae
(6.09% vs. 2.42%, P=0.035), Prevotellaceae (1.46% vs. 1.14%,
P=0.035), Coriobacteriaceae (1.19% vs. 0.74%, P=0.035), and
Peptostreptococcaceae (0.89% vs. 0.45%, P=0.035) were signifi-
cantly enriched in CRC patients. Peptostreptococcaceae was also
enriched in swab samples of CRC patients, whereas the relative
abundance was higher compared to cancerous tissue. Genera
Peptostreptococcus (Peptostreptococcaceae), Porphyromonas, Mogibacter-
ium,Anaerococcus,Slackia,Anaerotruncus,Collinsella(Coriobacteriaceae),
Desulfovibrio,EubacteriumandParaprevotellawerealsomoreprevalentin
patients compared tocontrols (Figure 4B).
Erysipelotrichaceae, Prevotellaceae, Coriobacteriaceae (Collin-
sella), Peptostreptococcus, and Anaerotruncus (Clostridiales), which were
enriched in patients were classified as the key phylotypes that
contribute to the separation of intestinal lumen microbiota
structure in CRC patients and healthy individuals.
Identification of Key OTUs Responsible for Structural
Segregation of the Mucosa-associated Microbiota of
Cancer and Control Samples
Sears and Pardoll proposed an Alpha-Bug hypothesis in a recent
report–certain microbiome members that possessing unique
virulence traits, such as enterotoxigenic Bacteroides fragilis, are not
only directly pro-oncogenic but are capable of remodeling the
microbiome as a whole, thus promoting mucosal immune
responses and colonic epithelial cell changes and resulting in
colon cancer [28]. We hypothesized that this Alpha-Bug
potentially belongs to the mucosa-associated bacteria community.
Firstly, LEfSe, a strict tool, was utilized to identify dominant
OTUs. We found six dominant OTUs, which were all reduced in
cancerous tissue and these key contributors belong to Faecalibacter-
ium, Dorea, uncultured Ruminococcus sp., Ruminococcus gnavus, Lachnos-
piracea, and Peptostreptococcaceae. We generated a PLS-DA
model was generated to find more OTUs that potentially
contribute to the separation. OTUs that were differentially
distributed were selected according to their variable importance
Table 3. Phylotypes significantly different between cat and pa2t or cat and pa10t.
Taxonomic Rank cat(%) pa2t(%) p value# pa10t(%) p value*
genus Ochrobactrum 0.026 0.054 0.035 0.116
genus Paraprevotella 0.002 0.011 0.012 0.013
genus Phascolarctobacterium 0.154 0.303 0.336 0.045
genus Parabacteroides 0.536 0.687 0.862 0.048
family Ruminococcaceae 4.24 7.12 8.28 0.031
genus Faecalibacterium 1.68 3.20 4.20 0.032
class Bacilli 14.56 7.31 4.82 0.015
genus Bacillus 0 0.040 0.016 0.001
class Alphaproteobacteria 0.136 0.250 0.017 0.725 0.024
genus Methylobacterium 0.021 0.025 0.048 0.032
genus Acidocella 0.002 0.020 0.052 0.029
Statistical analysis was performed by Mann-Whitney test. Data of cat, pa2t and pa10t were relative abundance (percentage) of all sequences in each group.
#P value between cat and pa2t.
*P value between cat and pa10t. P value had no statistically significant difference ($0.05) were not shown.
doi:10.1371/journal.pone.0039743.t003
Figure 4. Relative abundance of significantly different genera
between CRC patients and healthy controls. (A) Genera different
between swp and swc. (B) Genera differing between stp and stc. The
Mann-Whitney test was used to evaluate the importance of compar-
isons between indicated groups. *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0039743.g004
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identified as being relatively important contributors (four of these
were enriched in cat; the others were reduced). These were
members of Lachnospiracea (14), Bacteroidaceae (6), Rumino-
coccaceae (6), and Peptostreptococcaceae (1); all exhibited
significant differences between cat and pa10t (P,0.05, Mann-
Whitney test). Two additional OTUs closely related to Rumino-
coccus gnavus and 4 OTUs belonging to genus Faecalibacterium were
also found to be reduced in cancerous tissue.
In addition, this analysis was performed using mucosa-adherent
bacterial samples. Two dominant OTUs for each of the
Peptostreptococcus sp. and Parvimonas sp. were enriched over 100
fold in CRC patients. One OTU related to Bacteroides caccae and
one related to Clostridium sp. were also enriched. Two OTUs
belonging to Faecalibacterium and Blautia were significantly reduced
in patients. We selected 69 OTUs with VIP.2 that were
important contributors according to PLS-DA, and 64 of them
were significantly different between CRC patients and controls.
Among them, six OTUs belonging to genus Faecalibacterium and six
OTUs belonging to genus Blautia were reduced in patients with
CRC. Additionally, two OTUs related to Fusobacterium varium, one
OTU related to Bacteroides xylanisolvens, and one OTU related to
Dialister pneumosintes were highly enriched in patients with CRC.
Two additional OTUs related to Peptostreptococcus sp. and Parvimonas
sp. were enriched in patients with CRC.
Discussion
We speculated that the mucosa-associated microbiota primarily
acts through direct interaction with the host and that intestinal
lumen microbiota primarily acts through cometabolism or
metabolic exchange with the host. We utilized barcoded multi-
plexed-454 pyrosequencing to compare the bacterial composition
of cancerous tissue and intestinal lumen of patients with CRC to
those of healthy controls. We also investigated the mucosa-
adherent microbial composition by using rectal swab samples
because the bacterial community is potentially altered by following
bowel cleansing. We found that the structure of microbiota in
cancerous tissue differs significantly differs from that of the
intestinal lumen. The relative abundance of dominant phyla
Firmicutes, Bacteroidetes, and Proteobacteria and dominant
genera Bacteroides, Streptococcus, and Pseudobutyrivibrio were all
different. Firmicutes, which has been demonstrated to enhance
energy harvest from diet, was highly enriched in intestinal lumen
[29,30,31]. Moreover, the predominant genus Pseudobutyrivibrio
exhibited butyrate as a principal metabolite, as well as lactic acid
and formic acid [32]. In contrast, Bacteroidetes, which is highly
enriched in mucosa, may be primarily involved in interactions
with the intestine [33]. The highly enriched major Gram-negative
bacteria Proteobacteria in mucosa, with an outer membrane
composed of lipopolysaccharides, potentially exhibits direct
interaction with intestinal cells through bacterial secretion systems
such as T2SS or T3SS [34,35]. Additionally, enriched Fusobac-
teria and Synergistetes in mucosa also infects intestinal tissue
[36,37,38]. As expected, our findings indicated that the structure
of mucosa-adherent microbiota was more similar to tissue
microbiota. Mucosa-adherent microbial structures also exhibited
similarity with lumen microbiota; this is partially due to the
unavoidable feces crossover on the swabs. We postulated that the
swab microflora represents a combination of fecal microflora and
a mucosa population less closely attached, whereas the tissue
microbiota represents closely colonized bacteria. Unweighted
Unifrac PCA analysis confirmed this result. Overall microbial
structures were similar between cancerous tissue and noncancer-
ous tissue. The intestinal lumen microbiota and mucosa-adherent
microbiota were structurally separated in CRC patients compared
to matched microbiota in healthy individuals.
SearsandPardollhaveproposedanAlpha-Bughypothesis–certain
microbiomes members not only are directly pro-oncogenic but are
capableofremodelingthemicrobiomeasawholetopromotecancer
progression. We hypothesized that there are also certain micro-
biomes that can protect against pathogens and prevent the
progression of cancer; for example, the segmented filamentous
bacteria found inmouse intestineinduce inflammationand protects
against pathogens [39,40]. Pyrosequencing data indicate Faecalibac-
terium is significantly less abundant in cancerous tissue compared to
normal tissue. This finding was confirmed in mucosa-adherent
microbiota of CRC patients compared to healthy controls.
Additionally, four OTUs that were identified as key contributors to
differentiatethemicrobialstructuresoftumorandnormaltissuewere
significantly reduced. Moreover, six OTUs identified as key
contributors to differentiate mucosa-adherent microbial structure
of CRC patients and healthy individuals were significantly reduced.
These results demonstrated that Faecalibacterium are negatively
correlated to CRC. Sokol et al. reported that F. prausnitzii, the main
species of Faecalibacterium, exhibits an anti-inflammatory effects on
colitis by blocking NF-kB expression and IL-8 secretion [41].
Furthermore, F. prausnitzii induces colonization resistance against
pathogens [42]. We hypothesized that Faecalibacterium plays a
probiotic role in CRC. Interestingly, we found that three OTUs
closely related to Ruminococcus gnavus are significantly reduced in
cancerous tissue. R. gnavus produces an antibacterial peptide that
protects hosts against pathogens [43]. Moreover, the amount of the
probioticBifidobacterium,whichcounteractspathogencolonizationby
competing for adhesion sites and secreting antibacterial peptides
[44], was significantly reduced in CRC patients. In addition,
Fusobacterium is a key phylotype that is significantly enriched in swab
samplesofCRCpatientsandispositivelyassociatedwithCRC.Two
oftheenrichedOTUsidentifiedaskeycontributorsarecloselyrelated
to Fusobacterium varium, which can induce ulcerative colitis [36,45].
Fusobacterium wasalsoenrichedintumortissue,althoughthisfinding
wasnotstatisticallysignificant(datanotshown).Takentogether,our
findingsindicatethatFusobacteriumwascloselyassociatedwithCRC.
Two recently published reports confirmed thses results [46,47].
Porphyromonas, which is affiliated with family Porphyromonadaceae,
was also found in abundance in CRC patients. Although rarely
reportedintheintestine,P.gingivalis,amainspeciesofPorphyromonas,
penetratesperiodontaltissue,disruptthehostcellactivity,andalters
the microbiota composition to induce periodontitis [48,49,50].
However, Peptostreptococcus is commensal bacteria that can infect
multiple sites of the body including intestinal mucosa under
immunosuppressed or traumatic conditions. These results suggest
thatitispossiblethatthemicrobiomeinmucosamainlyplaysitsrole
by directly interacting withthe host.
Metabolites and antigens produced by microflora of the
intestine may play vital roles in influencing CRC risk by
interacting with host metabolism and immunity [51,52]. Regard-
ing microbiota of the intestinal lumen, the predominant
phylotypes in CRC patients–Erysipelotrichaceae, Prevotellaceae,
and Coriobacteriaceae–are all associated with metabolic disorders
or energy metabolism. Erysipelotrichaceae, Prevotellaceae, and
Coriobacteriaceae are enriched in obese human and obese mouse,
as well as in ‘‘Western diet’’ or high-fat diet associated mouse, and
they are closely related to energy production or adiposity
[53,54,55,56,57,58]. Epidemiological studies have established a
strong association between ‘‘Western diet’’ or obesity (and its
related metabolic diseases) and colorectal cancer. It seems that the
enrichment of certain members of lumen microbiota is the basis
Colorectal Cancer Microbiota
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colorectal cancer. Furthermore, the enriched bacteria Desulfovibrio
reduces sulfate in order to produce hydrogen sulfide, which has
been reported as a possible contributing risk factor of CRC
[59,60]. In addition, Wang et al. found that butyrate-producing
bacteria in the feces of CRC patients were reduced [7], and that
butyrate plays an important role in cancer prevention [61]. These
discoveries suggest that intestinal lumen microflora potentially
exert an important influence on CRC risk through cometabolism
or metabolic exchange with the host.
In conclusion, our results suggest that intestinal microbiota are
associated with CRC risk, and that intestinal lumen microflora
potentially influence CRC risk via cometabolism or metabolic
exchange with the host. It is possible that mucosa-associated
microbiota affect CRC risk largely through direct interaction with
the host. The Alpha-Bug hypothesis may be suggested as follows:
certain microbiome members of mucosa-associated microbiota,
are not only directly pro-oncogenic but are capable of remodeling
the intestinal lumen microbiota as a whole to promote progression
of colon cancer. Our results represent a comprehensive picture of
the microbial structure of CRC patients and help to further
elucidate CRC etiology. However, more detailed information
concerning mucosa-associated microbiota and lumen microbiota is
essential. Moreover, the exact mechanisms contributing to the
underlying changes remain obscure. Thus future studies are
warranted to explore CRC microbiota and the different roles of
such microbiota in CRC progression.
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